Cleared Abbreviated

K032342 - COULTER LH 750 HEMATOLOGY ANALYZER

K032342 is an FDA 510(k) clearance for COULTER LH 750 HEMATOLOGY ANALYZER, manufactured by Beckman Coulter, Inc.. The device is a Class 2 Hematology device with product code GKZ cleared through the Abbreviated 510(k) pathway after a 59-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2003
Decision
59d
Days
Class 2
Risk

K032342 is an FDA 510(k) clearance for the COULTER LH 750 HEMATOLOGY ANALYZER. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Miami, US). The FDA issued a Cleared decision on September 26, 2003 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Beckman Coulter, Inc. devices

FDA 510(k) Submission Details - K032342

510(k) Number K032342 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 29, 2003
Decision Date September 26, 2003
Days to Decision 59 days
Submission Type Abbreviated
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 113d · This submission: 59d
Pathway characteristics
Standards-based clearance path.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 295
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K032342.
BD FACS 7-COLOR SETUP BEADS
K040026 · Becton Dickinson Immunocytometry Systems · Sep 2004
BD FACSCANTO SYSTEM
K040725 · Becton Dickinson Immunocytometry Systems · Sep 2004
SYSMEX AUTOMATED HEMATOLOGY ANALYZER, XE-2100 SERIES (XE-2100, XE-2100L)
K040073 · Sysmex America, Inc. · Mar 2004
IMMATURE GRANULOCYTE (IG) PARAMETER ON THE SYSMEX MODEL XE-2100 AUTOMATED HEMATOLOGY ANALYZER
K032039 · Sysmex America, Inc. · Sep 2003
ADVIA 60 HEMATOLOGY ANALYZER
K032524 · Bayer Healthcare, LLC · Sep 2003
COULTER LH 500 HEMATOLOGY ANALYZER
K032000 · Beckman Coulter, Inc. · Aug 2003